{"summary":"\nWorldwide global regulatory support through cross-functional interactions with manufacturing, brand and therapeutic area teams for biotechnology products within the company's portfolio. Regulatory strategic planning, authoring of regulatory submissions (CMC), coordination of work by SMEs and production facility teams in multitasking environment to ensure timely completion of regulatory documentation. Professional analytical data monitoring, assessment of change controls and deviations, identifying risks with appropriate contingency strategies. Leading regulatory filing strategies and guiding product development on different phases - Ph 1-3 clinical to BLA\/MAA. Knowledge of Technology Transfer and IP tools. \n\u2022\tExperience in global GXPs related to pharmaceutical quality of biologics throughout the product lifecycle: from pre-IND to post-approval. As an ex-FDA employee deep understanding of FDA 21st Century Managed Review Process, professional knowledge of the laws, guidances and regulations (FDA, EMA). Prooven records of Product Quality (CMC) Review of original BLAs, INDs, pre-BLA packages, Drug Master Files. \n\u2022\tActive participation in FDA Pre-License and Pre-Approval Inspections of biotech facilities in the frame of BLA and PAS approval process. Deep knowledge of FDA\/EMA requirements for compliance and quality documentation within manufacturing facility. Extensive experience in review of drugs filled into pre-filled syringes, deep involvement into interdisciplinary review of Combination Products with Center for Devices and Radiological Health (U.S. FDA). \n\u2022\tExceptional oral and written communication skills: presentations at FDA internal regulatory and  international scientific meetings, writing of professional review reports, 15 scientific articles as a lead author. Proficient and creative analyst and presenter of complex technical information to diverse audiences. Inter-agency (FDA-NIH-CDC) and scientific international collaborative research experience (in US, Germany and Russia). Good professional network. FDA CBER Leveraging Collaboration Award \n\u2022\tHighly experienced and recognized biomedical scientist with a focus on stem cells biology, proteomics; molecular diagnostics, biochemistry and genetics of mammalian viruses, immunology and anti-viral vaccine development. Extensive experience in proteomics and Mass Spectrometry, biology of human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSCs).","pastPositions":[{"endedOn":{"month":5,"year":2023},"companyName":"ADC Therapeutics","title":"Director of CMC Regulatory Affairs","companyUrn":"urn:li:fs_salesCompany:8297253","posId":1,"current":true,"startedOn":{"month":2,"year":2021}},{"endedOn":{"month":5,"year":2017},"companyName":"FDA, Center for Drug Evaluation and Research, Office of Pharmaceutical Quality","title":"Product Quality Reviewer","companyUrn":"urn:li:fs_salesCompany:4652","posId":1,"current":true,"startedOn":{"month":5,"year":2015}}],"lastName":"Pripuzova, PhD","objectUrn":"urn:li:member:98901516","geoRegion":"San Diego, California, United States","fullName":"Natalia Pripuzova, PhD","firstName":"Natalia","currentPositions":[{"companyName":"Shoreline Biosciences, Inc.","title":"Director of CMC Regulatory Affairs","tenureAtCompany":{"numYears":1},"companyUrnResolutionResult":{"employeeCountRange":"51-200","headquarters":{"geographicArea":"CA","country":"United States","city":"La Jolla","postalCode":"92037"},"website":"https:\/\/www.shorelinebio.com\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/shoreline-biosciences-inc\/","industry":"Biotechnology Research"},"startedOn":{"month":6,"year":2023},"companyUrn":"urn:li:fs_salesCompany:68901559"}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1619456748981?e=1723075200&v=beta&t=0SuP19xlFkwp87sTekjxdKgTBD9cdXF5jgy3oC20zHY","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1619456748981?e=1723075200&v=beta&t=tATWgIvgik83t5N4e_0omkDIacBjJD2YzgdJou6-nNU","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1619456748981?e=1723075200&v=beta&t=3v9CDzJhPVAoioe71naHEWVZKJv1Pd2RGNJDW6Jr0_0","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1619456748981?e=1723075200&v=beta&t=Ul_dTQv86WEza99dfxpNJyRhmt53C9Ny19kMTPsHBGU","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/C5603AQHMXzaJai0XGg\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2000},"degree":"MS","eduId":61742935,"schoolUrn":"urn:li:fs_salesSchool:15097724","school":"urn:li:fs_salesSchool:15097724","fieldsOfStudy":["Biology, General"],"schoolName":"Lomonosov Moscow State University (MSU)","startedOn":{"year":1995}},{"endedOn":{"year":2005},"degree":"PhD","eduId":61742531,"fieldsOfStudy":["virology"],"schoolName":"Chumakov Moscow Institute of Poliomyelitis and Viral Encephalitidies, RAMSs","startedOn":{"year":2000}}],"skills":[{"numOfEndorsement":9,"name":"Cell Biology"},{"numOfEndorsement":2,"name":"Protein Assays"},{"numOfEndorsement":7,"name":"Genomics"},{"numOfEndorsement":4,"name":"Molecular Cloning"},{"numOfEndorsement":18,"name":"Molecular Biology"},{"numOfEndorsement":3,"name":"Virology"},{"numOfEndorsement":4,"name":"RT-PCR"},{"numOfEndorsement":8,"name":"Genetics"},{"numOfEndorsement":13,"name":"Protein Expression"},{"numOfEndorsement":18,"name":"Biochemistry"},{"numOfEndorsement":3,"name":"Bioinformatics"},{"numOfEndorsement":10,"name":"qPCR"},{"numOfEndorsement":5,"name":"Immunology"},{"numOfEndorsement":3,"name":"DNA sequencing"},{"numOfEndorsement":3,"name":"ELISA"},{"numOfEndorsement":11,"name":"Cell Culture"},{"numOfEndorsement":3,"name":"Laboratory"},{"numOfEndorsement":3,"name":"recombinant DNA technology"},{"numOfEndorsement":7,"name":"DNA"},{"numOfEndorsement":2,"name":"PCR"},{"numOfEndorsement":2,"name":"Vaccines"},{"numOfEndorsement":4,"name":"Microbiology"},{"numOfEndorsement":3,"name":"Assay Development"},{"numOfEndorsement":6,"name":"Protein Chemistry"},{"numOfEndorsement":3,"name":"Animal Models"},{"numOfEndorsement":5,"name":"Cell"},{"numOfEndorsement":2,"name":"Antibodies"},{"numOfEndorsement":4,"name":"Western Blotting"},{"numOfEndorsement":2,"name":"Sequencing"},{"numOfEndorsement":1,"name":"In Vivo"},{"numOfEndorsement":2,"name":"Immunoprecipitation"},{"numOfEndorsement":3,"name":"Protein Purification"},{"numOfEndorsement":2,"name":"Proteomics"},{"numOfEndorsement":3,"name":"Mass Spectrometry"},{"numOfEndorsement":1,"name":"Immunohistochemistry"},{"numOfEndorsement":1,"name":"SDS-PAGE"},{"numOfEndorsement":1,"name":"Transfection"},{"numOfEndorsement":1,"name":"Cancer Research"},{"numOfEndorsement":2,"name":"Drug Discovery"},{"numOfEndorsement":2,"name":"Immunofluorescence"},{"numOfEndorsement":1,"name":"Purification"},{"numOfEndorsement":2,"name":"Tissue Culture"},{"numOfEndorsement":1,"name":"Microscopy"},{"numOfEndorsement":1,"name":"RNA isolation"},{"numOfEndorsement":1,"name":"DNA extraction"},{"numOfEndorsement":1,"name":"Confocal Microscopy"},{"numOfEndorsement":1,"name":"GLP"},{"numOfEndorsement":1,"name":"Flow Cytometry"},{"numOfEndorsement":1,"name":"In Vitro"},{"numOfEndorsement":1,"name":"Stem Cells"}],"numOfConnections":662,"patents":[],"headline":"Director of CMC Regulatory Affairs at Shoreline Biosciences","courses":[{"name":"New Reviewers Blended Learning Program at CDER, FDA","number":""},{"name":"Drug Manufacturing Facility Inspections, FDA, CDER","number":""},{"name":"Workshop on Cell and Tissue-based regenerative Medicine Products, USP, November, 2013","number":""},{"name":"Principles of Clinical Pharmacology, NIH, 2013-2014","number":""},{"name":"Generation of hiPSC from blood, NIH FAES, August 2013","number":""},{"name":"CBER New Reviewer Training, FDA, June, 2013","number":""},{"name":"Xevo G2 Q-Tof Biomolecule training. Waters, Beverly, MA, August 13-17, 2012","number":""},{"name":"Waters trainings on \u201cProtein HPLC\u201d and \u201cIntroduction to MassLinx\u201d, \u201cBiopharmaLinx\u201d","number":""},{"name":"NIH FAES training \u201cProtein Bioinformatics\u201d","number":""},{"name":"\u201cInduced pluripotent stem cells: Principals and methods\u201d, NIH FAES","number":""},{"name":"\"Scientific Writing for Publication\" and \u201cProofreading skills\u201d, FDA, CBER","number":""},{"name":"\u201cBiostatistics\u201d, FDA, CBER","number":""},{"name":"FEBS Advanced Course \" Evolution of mitochondria and chloroplasts\", Munich, Germany","number":""},{"name":"FEBS Practical Course \"Viral Expression Vectors for research and Biotechnology\", Tartu, Estonia","number":""},{"name":"FEBS Advance Course \"New molecular strategies to treat neurodegenerative diseases\", Portugal","number":""},{"name":"Certificate in Medical Virology of Russian Academy of Medical Sciences, Moscow","number":""},{"name":"FEBS Lecture Course \"Molecular mechanisms in homeostasis and disease\", Spetses, Greece","number":""}],"certifications":[],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/natalia-pripuzova-phd-81015629","organizations":[],"location":"San Diego, California, United States","publications":[{"name":"Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis.","publishedOn":{"month":2,"day":7,"year":2015},"publisher":"Stem Cell Research \/ Elsevier, 2015 Feb 7;14(3):323-338","url":"http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1873506115000264#","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Stability of structured Kaposi sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization.","publishedOn":{"month":1,"day":7,"year":2015},"publisher":"J Virol. 2015 Mar;89(6):3256-74","url":"http:\/\/jvi.asm.org\/content\/early\/2015\/01\/02\/JVI.03721-14.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Non-targeted identification of prions and amyloid-forming proteins from yeast and mammalian cells","publishedOn":{"month":8,"day":7,"year":2013},"publisher":"The Journal of Biological Chemistry (JBC)","url":"http:\/\/www.jbc.org\/content\/early\/2013\/08\/07\/jbc.M113.485359.abstract?sid=f47f6f1b-c2a9-4ed0-b359-ce9652a965c3","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Comparative Proteomic Analysis of Human Embryonic Stem Cells (ESCs) and Human Induced Pluripotent Stem Cells (iPSCs) of Different Origin","publishedOn":{"month":3,"day":13,"year":2013},"publisher":"Pressurebiosciences","url":"http:\/\/www.pressurebiosciences.com\/downloads\/publications\/2013-03\/US-HUPO-2013-Poster-Natalia-Pripuzova-FDA.pdf","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Exploring of Primate Models of Tick-Borne Flaviviruses Infection for Evaluation of Vaccines and Drugs Efficacy","publishedOn":{"month":4,"day":9,"year":2013},"publisher":"PLoS One. 2013 Apr 9;8(4):e61094","url":"http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0061094","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Development of real-time PCR array for simultaneous detection of eight human blood-borne viral pathogens.","publisher":"PLoS One. 2012;7(8):e43246","url":"http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0043246","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression.","publisher":"J Virol. 2011 Mar;85(6):2620-30.","url":"http:\/\/jvi.asm.org\/content\/85\/6\/2620.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Failure to confirm XMRV\/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.","publisher":"Science. 2011 Nov 11;334(6057):814-7.","url":"http:\/\/www.sciencemag.org\/content\/334\/6057\/814.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors.","publisher":"Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15874-9. doi:","url":"http:\/\/www.pnas.org\/content\/107\/36\/15874.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Safety evaluation of chimeric Langat\/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.","publisher":"J Med Virol. 2009 Oct;81(10):1777-85.","url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.21587\/abstract;jsessionid=FE0CA4CEAB2271E8DB271D8DD62EADD5.d02t02","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.","publisher":"J Virol. 2007 Feb;81(3):1062-71.","url":"http:\/\/jvi.asm.org\/content\/81\/3\/1062.long","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"name":"Isolation and Analysis of Prion and Amyloid Aggregates from Yeasts Cells","publishedOn":{"year":2017},"publisher":"Cold Spring Harbor Protocols","url":"https:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/28148850","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]},{"publishedOn":{"month":1,"day":21,"year":2022},"description":"Induced pluripotent stem cells (iPSC)-based technologies are now being progressed toward clinical use, such as cell therapy-based medicinal products. This has created a need for approaches to monitor the quality of human induced pluripotent stem cells (hiPSCs) during their large-scale production. We applied comparative proteomics to identify changes in cellular proteomes during cell culturing and subsequent differentiation into embryoid bodies (EBs) between normally grown (control) hiPSCs and \u201covergrown\u201d hiPSCs.","url":"https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780323998925000086","name":"Proteomic Approach for Creation of the Protein Marker Panels to Control the Quality of Human iPCS","publisher":"Elsevier","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAXlHgwB9za-2TYIF6lPfof0A48dFLMzuWY,NAME_SEARCH,VWeP)"}]}],"positions":null,"posts":[{"createdAt":1715112300000,"insightId":"a3994753-9df5-42df-b26f-3665ff7fff41","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7191572272585871361,7193702515832471552)","threadUrn":"urn:li:activity:7191572272585871361","reactionsCount":0,"commentsCount":1,"canComment":true},"commentary":{"attributes":[],"text":"Wow ! 1st author at Nature Communications is definitely a great achievement!!! Congratulations Chao!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7191572272585871361"}}},{"createdAt":1711549740000,"insightId":"04227bf6-8c94-4181-b27c-754ea8144643","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7174417433728843776,7178760006568144896)","threadUrn":"urn:li:activity:7174417433728843776","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Hi Sergei, congratulations! If you are in need for a high level professional help in patent applications and patent portfolio strategizing please let me know."},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7174417433728843776"}}}]}